Form 4 for ANGO ANGIODYNAMICS INC
Accepted 2021-07-23 00:00:00 ET · period of report 2021-07-21 · accession 0001567619-21-013914 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-07-23 | 2021-07-21 | ANGO | ROSENZWEIG RICHARD C | SVP, GC | A - Grant | $0.00 | +3,098 | 14.1K | +28% | $0 |
| DM | 2021-07-23 | 2021-07-21 | ANGO | ROSENZWEIG RICHARD C | SVP, GC | A - Grant | $0.00 | +14.6K | 8,418 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-07-21 | A | A | 3,098 | $0.00 | 14,098 | D | — | — | (F1) The acquisition of 3,098 shares of common stock ("Common Stock") of AngioDynamics, Inc. (the "Company") represents 3,098 restricted stock units, each of which represents a contingent right to receive one share of Common Stock. These restricted stock units vest in four equal annual installments beginning on July 21, 2022, such that 25% of the restricted stock units will vest on each of July 21, 2022, 2023, 2024 and 2025. |
| 2 | Derivative | Performance Right | 2021-07-21 | A | A | 6,197 | $0.00 | 6,197 | D | — · — to — | 6,197 Common Stock | (F2) Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period in accordance with performance metrics as determined by the compensation committee. Any shares that do not vest at the end of the performance period will be forfeited. |
| 3 | Derivative | Non-Qualified Stock Option (right to buy) | 2021-07-21 | A | A | 8,418 | $0.00 | 8,418 | D | $10.27 · 2022-07-21 to 2031-07-21 | 8,418 Common Stock | (F3) These stock options vest in four equal annual installments beginning on July 21, 2022, such that 25% of the options will vest on each of July 21, 2022, 2023, 2024 and 2025. |